Cash Flow Xvivo Perfusion AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
38.00
199.00
94.00
22.00
6.00
-57.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-68.00
-79.00
-39.00
-22.00
-23.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
101.00
111.00
46.00
27.00
-12.00
-12.00
Cash Flow from Investing Activities
-258.00
-243.00
-161.00
-197.00
-187.00
-266.00
Cash Flow from Financing Activities
72.00
-10.00
418.00
-6.00
234.00
482.00
Net Cash Inflow / Outflow
-123.00
-130.00
299.00
-152.00
44.00
194.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-38.00
12.00
-3.00
24.00
9.00
-9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Xvivo Perfusion AB
Figures in Million
consolidated Cash Flow Results
Change(SEK)
Change(%)
Profit Before Tax
38.561
328
-290.00
-88.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-68.729
44
-112.00
-256.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
101.066
413
-312.00
-75.53%
Cash Flow from Investing Activities
-258.41
-456
198.00
43.33%
Cash Flow from Financing Activities
72.246
-156
228.00
146.31%
Net Cash Inflow / Outflow
-123.43
-160
37.00
22.86%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-38.332
39
-77.00
-198.29%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -9.19% vs 140.43% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
101.07
111.29
-9.19%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
